April 9, 2022

Junshi Biosciences and Coherus Present Results of Phase 3 Study of Toripalimab in First Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma at 2022 AACR Annual Meeting

– Toripalimab plus chemotherapy provided superior progression free survival, overall survival, overall response rate and duration of response compared to chemotherapy alone – SHANGHAI, China, and REDWOOD CITY, Calif., April 09, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”)

>

Belgian Professional Soccer Club KMSK Deinze and DEA Pays an Official Visit to the Mayor of Deinze; Announcement of a Strategic Partnership With the City of Deinze

Local Government x Professional Soccer Club to Revitalize the Community with the World’s First Web3 Collaboration Featured Image for Digital Entertainment Asset Pte. Ltd SINGAPORE, April 08, 2022 (GLOBE NEWSWIRE) — Naohito Yoshida, Founder & CEO of Digital Entertainment Asset Pte. Ltd. (“DEA”), a Singapore-based global GameFi platform company, and

>

Taiwan Coast Guard takes delivery of two new vessels

The Coast Guard Administration (CGA) on Friday took delivery of two new vessels — including one 600-ton armed patrol corvette — that it said will patrol coastal areas of Taiwan.The corvette, named the Cijin (hull number CG-605), was delivered at the …

>